Blincyto and Septic shock - a phase IV clinical study of FDA data

Summary:

Septic shock is reported as a side effect among people who take Blincyto (blinatumomab), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Cellcept, and have Acute lymphocytic leukaemia recurrent.

The phase IV clinical study analyzes which people have Septic shock when taking Blincyto. It is created by eHealthMe based on reports of 6,058 people who have side effects when taking Blincyto from the FDA, and is updated regularly.

What is Blincyto?

Blincyto has active ingredients of blinatumomab. eHealthMe is studying from 6,058 Blincyto users. Check the latest studies of Blincyto.

What is Septic shock?

Septic shock (shock due to blood infection) is found to be associated with 1,746 drugs and 3,392 conditions by eHealthMe. Check the latest studies of Septic shock.

On Jul, 09, 2026

6,058 people reported to have side effects when taking Blincyto.
Among them, 36 people (0.59%) have Septic shock.

Among these 36 people:

How long have people been on Blincyto when they have Septic shock? *

What is the gender of people who have Septic shock when taking Blincyto? *

female: 51.52 %
male: 48.48 %

What is the age of people who have Septic shock when taking Blincyto? *

What are other drugs people take besides Blincyto? *

Besponsa: 9 people, 25.00%
Prograf: 9 people, 25.00%
Cellcept: 9 people, 25.00%
Amlodipine: 2 people, 5.56%
Sprycel: 2 people, 5.56%
Nesina: 2 people, 5.56%
Methotrexate: 2 people, 5.56%
Busulfex: 2 people, 5.56%
Dexamethasone Sodium Phosphate: 2 people, 5.56%
Trichlormethiazide: 2 people, 5.56%

What are other side effects people have besides Septic shock? *

Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 13 people, 36.11%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 7 people, 19.44%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 6 people, 16.67%
Hepatotoxicity (chemical-driven liver damage): 6 people, 16.67%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 5 people, 13.89%
Oral Disorder (mouth disease): 4 people, 11.11%
Venoocclusive Disease (small veins in the liver are obstructed): 4 people, 11.11%
Pneumonia: 4 people, 11.11%
Central Nervous System Leukaemia (cancer of central nervous system): 4 people, 11.11%
Fever: 3 people, 8.33%

What are the existing conditions these people have? *

Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 14 people, 38.89%
B Precursor Type Acute Leukaemia (lymphoid cancer): 11 people, 30.56%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 30.56%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 2 people, 5.56%
Precursor B-Lymphoblastic Lymphoma Recurrent (precursor b-cell cancer recurrent): 2 people, 5.56%
Immunodeficiency Disorders: 2 people, 5.56%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 2 people, 5.56%
Bone Marrow Conditioning Regimen: 2 people, 5.56%
Lymphoma (cancer that begins in immune system cells): 1 person, 2.78%
Infection: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Blincyto and have Septic shock?

- Check whether Septic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Blincyto:

Blincyto (6,058 reports)

Septic shock treatments and more:

Septic shock (51,128 reports)

Browse all side effects of Blincyto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic shock:

Septic shock (1,746 drugs)

Browse all the conditions that are associated with Septic shock:

Septic shock (3,392 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on blinatumomab (the active ingredients of Blincyto) and Blincyto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.